CNFinance (NYSE:CNF) and Hillstream Biopharma (NASDAQ:CNTN) Financial Contrast

CNFinance (NYSE:CNF) and Hillstream Biopharma (NASDAQ:CNTN) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends and earnings.

Institutional & Insider Ownership

1.2% of Hillstream Biopharma shares are owned by institutional investors. 25.8% of CNFinance shares are owned by insiders. Comparatively, 3.3% of Hillstream Biopharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares CNFinance and Hillstream Biopharma”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CNFinance	$135.76 million	0.11	-$65.43 million	$2.20	1.00
Hillstream Biopharma	N/A	N/A	-$35.92 million	($0.50)	-4.44

Hillstream Biopharma has lower revenue, but higher earnings than CNFinance. Hillstream Biopharma is trading at a lower price-to-earnings ratio than CNFinance, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares CNFinance and Hillstream Biopharma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CNFinance	N/A	N/A	N/A
Hillstream Biopharma	N/A	-20.06%	-15.90%

Analyst Recommendations

This is a breakdown of recent ratings and target prices for CNFinance and Hillstream Biopharma, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CNFinance	1	1	0	1	2.33
Hillstream Biopharma	1	0	0	0	1.00

Volatility & Risk

CNFinance has a beta of -0.15, meaning that its share price is 115% less volatile than the S&P 500. Comparatively, Hillstream Biopharma has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500.

Summary

CNFinance beats Hillstream Biopharma on 8 of the 11 factors compared between the two stocks.

About CNFinance

CNFinance Holdings Limited, through its subsidiaries, provides home equity loan services in the People's Republic of China. It offers micro credit loan services for micro and small-enterprise owners; and loan lending agency services for financial institutions. The company provides bridge loan products, which are unsecured short-term loans to pay off borrowers' existing loans secured by real property. It operates approximately 87 branches and sub-branches in China. The company was founded in 1999 and is headquartered in Guangzhou, the People's Republic of China.

About Hillstream Biopharma

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company’s product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar; IC50 against PI3K-delta and HDAC6, which is also known to downregulate; c-myc, a cancer drug target; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor necrosis factor-alpha gene into cancer cells. The company was incorporated in 2019 and is based in Bridgewater, New Jersey.